CSIMarket
 


Homology Medicines, Inc.  (FIXX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Homology Medicines's Tangible Leverage Ratio

FIXX's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




FIXX Tangible Leverage Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Tangible Equity Change 21.18 % 25.55 % - - -
Y / Y Total Liabilities Change 13.8 % 37.07 % -66.68 % - -
Tangible Leverage Ratio MRQ 0.23 0.2 0.34 0.3 0.24
Overall Ranking # # # # #
Seq. Tangible Equity Change -9.45 % 63.4 % -10.5 % -8.48 % -6.19 %
Seq. Total Liabilities Change 4.47 % -4 % -0.97 % 14.57 % 25.83 %



Tangible Leverage Ratio third quarter 2019 Comment
Due to net new borrowings of 4.47%, Tangible Leverage Ratio detoriated to 0.23, below company's average Tangible Leverage Ratio.

Within Biotechnology & Drugs industry in the third quarter 2019, 38 other companies have achieved lower Tangible Leverage Ratio than Homology Medicines. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is FIXX Market Share?
Tangible Leverage Ratio third quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 39
Healthcare Sector # 137
Overall Market # 351


Tangible Leverage Ratio Statistics
High Average Low
0.34 0.25 0.18
(Mar 31 2019)   (Jun 30 2018)




Financial Statements
Homology Medicines's Tangible Equity $ 258 Millions Visit FIXX's Balance sheet
Homology Medicines's Total Liabilities $ 59 Millions Visit FIXX's Balance sheet
Source of FIXX's Sales Visit FIXX's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingSep 30 2019, within Biotechnology & Drugs Industry Tangible Leverage RatioSep 30 2019 MRQ Total LiabilitiesSep 30 2019 MRQ Tangible Equity
Protagonist Therapeutics, Inc.  0.62 $ 59.269  Millions$ 95.358  Millions
Chromadex Corp.  0.62 $ 15.997  Millions$ 25.769  Millions
Genocea Biosciences, Inc.  0.61 $ 19.111  Millions$ 31.373  Millions
Heska Corp  0.60 $ 70.328  Millions$ 117.261  Millions
Sun Biopharma, Inc.  0.60 $ 1.431  Millions$ 2.389  Millions
Assembly Biosciences, inc.  0.58 $ 66.856  Millions$ 114.851  Millions
Celldex Therapeutics, Inc.  0.58 $ 30.461  Millions$ 52.690  Millions
Strongbridge Biopharma Plc  0.54 $ 24.671  Millions$ 46.019  Millions
Diffusion Pharmaceuticals Inc.  0.53 $ 2.567  Millions$ 4.880  Millions
Foamix Pharmaceuticals Ltd.  0.52 $ 28.054  Millions$ 53.529  Millions
Xenetic Biosciences, Inc.  0.51 $ 4.616  Millions$ 9.016  Millions
Eloxx Pharmaceuticals, Inc.  0.50 $ 22.829  Millions$ 45.228  Millions
Trovagene, Inc.  0.50 $ 3.339  Millions$ 6.656  Millions
Halozyme Therapeutics, Inc.  0.50 $ 121.492  Millions$ 245.353  Millions
Cv Sciences, Inc.  0.48 $ 12.839  Millions$ 26.681  Millions
Scpharmaceuticals Inc.  0.47 $ 27.335  Millions$ 57.886  Millions
Pluristem Therapeutics Inc  0.45 $ 7.821  Millions$ 17.527  Millions
Momenta Pharmaceuticals, inc.  0.44 $ 121.844  Millions$ 273.906  Millions
Relmada Therapeutics, Inc.  0.42 $ 2.537  Millions$ 5.977  Millions
Akers Biosciences, Inc.  0.41 $ 1.373  Millions$ 3.385  Millions
Cohbar, Inc.  0.41 $ 4.441  Millions$ 10.959  Millions
Vermillion, Inc.  0.40 $ 4.706  Millions$ 11.827  Millions
Pdl Biopharma, Inc.  0.39 $ 227.727  Millions$ 590.085  Millions
Evelo Biosciences, Inc.  0.38 $ 30.594  Millions$ 80.546  Millions
Denali Therapeutics Inc.  0.38 $ 164.781  Millions$ 438.197  Millions
Oncternal Therapeutics, Inc.  0.37 $ 6.803  Millions$ 18.150  Millions
Volitionrx Ltd  0.34 $ 5.975  Millions$ 17.416  Millions
Gritstone Oncology, Inc.  0.33 $ 52.256  Millions$ 156.395  Millions
Zymeworks Inc.  0.33 $ 90.512  Millions$ 272.923  Millions
Proteostasis Therapeutics, Inc.  0.32 $ 22.788  Millions$ 70.121  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DDMXU's Profile

Stock Price

DDMXU's Financials

Business Description

Fundamentals

Charts & Quotes

DDMXU's News

Suppliers

DDMXU's Competitors

Customers & Markets

Economic Indicators

DDMXU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071